Li Yang Pharmaceutical

Chongqing Liyang Pharmaceutical Development Co., Ltd.

86-023-86502492

language

Liyang

Blog

—

Home

Biopharmaceutical Industry: A Powerful Innovation Engine Driving Global Market Competition

The deep integration of artificial intelligence technology has transformed drug development from "searching for a needle in a haystack" to "precise navigation."

2025

10-24

The Differences Between Intermediates, Active Pharmaceutical Ingredients (APIs), Excipients, and Preparations

Intermediate, a material generated during the active pharmaceutical ingredient (API) manufacturing process that requires further molecular transformation or purification before it can be finalized as an API.

2025

09-10

What are the differences between active pharmaceutical ingredients and finished dosage forms?

Active pharmaceutical ingredients (APIs) are the active components of drugs and cannot be used directly for clinical treatment. Pharmaceutical preparations, on the other hand, are drug formulations made by processing APIs with excipients, ready for direct use by patients.

2025

07-08

The method of decocting traditional Chinese medicine

First, pour the medicinal herbs into the decoction vessel and add cool water until the herbs are fully submerged. Allow them to soak for about an hour, enabling the traditional Chinese medicine to absorb moisture thoroughly and return to a fresh state. This process ensures that the active ingredients can be released more quickly and efficiently.

2025

06-04

What are the common types of liquid formulations?

This is a common type of liquid formulation, referring to a homogeneous system in which the drug is uniformly dispersed in the solvent in molecular or ionic form.

2025

05-30

Trends in the Pharmaceutical Industry

Breakthroughs in biotechnology and artificial intelligence are driving advancements in new drug development, paving the way for more innovative therapies and offering patients a wider range of treatment options.

2025

03-18

The Difference Between Traditional Chinese Medicine Preparations and Patent Chinese Medicines

The essential differences between traditional Chinese medicine preparations and proprietary Chinese medicines lie in their preparation methods, scope of application, and approval standards.

2025

01-09

Li Yang Company Promotional Brochure

China's first exclusive improved innovative drug—Glutathione Lozenges, featuring a new drug certificate and pharmaceutical registration approval, along with its patented invention.

2025

03-12

Congratulations on the launch of the website for Chongqing Liyang Pharmaceutical Development Co., Ltd.!

Chongqing Liyang Pharmaceutical Development Co., Ltd. was established in 2001 and is a high-tech enterprise specializing in the research and development of pharmaceutical formulations. The company has established robust technical platforms for injectable preparations, oral solid dosage forms, and topical semi-solid formulations, as well as advanced platforms for innovative dosage forms such as oral drug delivery systems and complex formulations like combination products. Our primary business areas include the generic development of high-end formulations, consistency evaluation, and the research and development of innovative pharmaceuticals.

2022

05-06

Pharmaceutical companies are actively engaged in the evaluation of generic drug consistency, and another company has successfully passed the evaluation at the start of May.

[Pharmaceutical Network Industry News] Compared to originator drugs, generic drugs have lower R&D costs and relatively less stringent approval requirements for market entry. To promote the high-quality development of generic drugs, the Generic Drug Consistency Evaluation program was introduced as a prerequisite for centralized procurement. Since the implementation of this policy, numerous pharmaceutical companies have actively participated in the evaluation process. As of May, another pharmaceutical company has announced that its drug has successfully passed the Generic Drug Consistency Evaluation. Specifically, Lissheng Pharmaceutical Co., Ltd. announced at noon on May 5th that it recently received the "Notice of Approval for Supplementary Drug Application" issued by the National Medical Products Administration for Donepezil Hydrochloride Tablets 5mg, confirming that the drug has met the standards set by the Generic Drug Consistency Evaluation program.

2022

05-06

< 1 2 > 跳转到页

National Service Hotline

86-023-86502492

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Powered By：www.300.cn SEO

Business License

Yu Public Security Network Registration No. 50010702505725